A retrospective molecular epidemiological scenario of carbapenemase-producing Klebsiella pneumoniae clinical isolates in a Sicilian transplantation hospital shows a swift polyclonal divergence among sequence types, resistome and virulome
Copyright © 2021 Elsevier GmbH. All rights reserved..
In this work, we assessed and characterized the epidemiological scenario of carbapenem-resistant Klebsiella pneumoniae strains (CR-Kp) at IRCCS-ISMETT, a transplantation hospital in Palermo, Italy, from 2008 to 2017. A total of 288 K. pneumoniae clinical isolates were selected based on their resistance to carbapenems. Molecular characterization was also done in terms of the presence of virulence and resistance genes. All patients were inpatients from our facility and clinical isolates were collected from several sources, either from infection or colonization cases. We observed that, in agreement with the Italian epidemiological scenario, initially only ST258 and ST512 clade II (but not from clade I) were identified from 2008 to 2011. From 2012 onwards, other STs have been observed, including the clinically relevant ST101 and ST307, but also others not previously observed in other Italian health settings, such as ST220 and ST753. The presence of genes involved in resistance and virulence was confirmed, and a heterogeneous genetic resistance profile throughout the years was observed. Our work highlights that resistance genes are rapidly disseminating between different and novel K. pneumoniae clones which, combined with resistance to multiple antibiotics, can derive into more aggressive and pathogenic multidrug-resistant strains of clinical importance. Our results stress the importance of continuous surveillance of CR Enterobacterales in health facilities so that novel STs carrying resistance and virulence genes that may become increasingly pathogenic can be identified and adequate therapies to adopted to avoid their dissemination and derived pathologies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:256 |
|---|---|
| Enthalten in: |
Microbiological research - 256(2022) vom: 30. März, Seite 126959 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Di Mento, Giuseppina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antimicrobial resistance |
|---|
| Anmerkungen: |
Date Completed 24.01.2022 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.micres.2021.126959 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335312675 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335312675 | ||
| 003 | DE-627 | ||
| 005 | 20231225225535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.micres.2021.126959 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1117.xml |
| 035 | |a (DE-627)NLM335312675 | ||
| 035 | |a (NLM)34995971 | ||
| 035 | |a (PII)S0944-5013(21)00266-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Di Mento, Giuseppina |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A retrospective molecular epidemiological scenario of carbapenemase-producing Klebsiella pneumoniae clinical isolates in a Sicilian transplantation hospital shows a swift polyclonal divergence among sequence types, resistome and virulome |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2022 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier GmbH. All rights reserved. | ||
| 520 | |a In this work, we assessed and characterized the epidemiological scenario of carbapenem-resistant Klebsiella pneumoniae strains (CR-Kp) at IRCCS-ISMETT, a transplantation hospital in Palermo, Italy, from 2008 to 2017. A total of 288 K. pneumoniae clinical isolates were selected based on their resistance to carbapenems. Molecular characterization was also done in terms of the presence of virulence and resistance genes. All patients were inpatients from our facility and clinical isolates were collected from several sources, either from infection or colonization cases. We observed that, in agreement with the Italian epidemiological scenario, initially only ST258 and ST512 clade II (but not from clade I) were identified from 2008 to 2011. From 2012 onwards, other STs have been observed, including the clinically relevant ST101 and ST307, but also others not previously observed in other Italian health settings, such as ST220 and ST753. The presence of genes involved in resistance and virulence was confirmed, and a heterogeneous genetic resistance profile throughout the years was observed. Our work highlights that resistance genes are rapidly disseminating between different and novel K. pneumoniae clones which, combined with resistance to multiple antibiotics, can derive into more aggressive and pathogenic multidrug-resistant strains of clinical importance. Our results stress the importance of continuous surveillance of CR Enterobacterales in health facilities so that novel STs carrying resistance and virulence genes that may become increasingly pathogenic can be identified and adequate therapies to adopted to avoid their dissemination and derived pathologies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antimicrobial resistance | |
| 650 | 4 | |a Carbapenems | |
| 650 | 4 | |a Hospital infection | |
| 650 | 4 | |a Klebsiella pneumoniae | |
| 650 | 4 | |a Surveillance | |
| 650 | 4 | |a Transplantation | |
| 650 | 7 | |a Bacterial Proteins |2 NLM | |
| 650 | 7 | |a beta-Lactamases |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 650 | 7 | |a carbapenemase |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 700 | 1 | |a Gona, Floriana |e verfasserin |4 aut | |
| 700 | 1 | |a Russelli, Giovanna |e verfasserin |4 aut | |
| 700 | 1 | |a Cuscino, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Barbera, Floriana |e verfasserin |4 aut | |
| 700 | 1 | |a Carreca, Anna Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Di Carlo, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Cardinale, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Monaco, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Campanella, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Mularoni, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Grossi, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Conaldi, Pier Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Douradinha, Bruno |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Microbiological research |d 1994 |g 256(2022) vom: 30. März, Seite 126959 |w (DE-627)NLM075034050 |x 1618-0623 |7 nnns |
| 773 | 1 | 8 | |g volume:256 |g year:2022 |g day:30 |g month:03 |g pages:126959 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.micres.2021.126959 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 256 |j 2022 |b 30 |c 03 |h 126959 | ||